• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下调 P-钙黏蛋白表达抑制胃癌细胞迁移和肿瘤生长

Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer.

机构信息

Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.

出版信息

Invest New Drugs. 2012 Aug;30(4):1404-12. doi: 10.1007/s10637-011-9710-9. Epub 2011 Jul 1.

DOI:10.1007/s10637-011-9710-9
PMID:21720740
Abstract

P-cadherin is frequently up-regulated in solid tumors such as gastric, colon, lung, pancreatic and breast cancers. Although P-cadherin promotes cadherin-mediated cell adhesion, the gastric cancer-linked regulation of P-cadherin has not been extensively investigated. In this study, we found epigenetic regulation of P-cadherin in human gastric cancer cells that was induced by treatment with DNA demethylating drug and histone deacetylase inhibitor. Silencing P-cadherin by using siRNA induces apoptosis in gastric cells and blocks expression of Tie-2, an angiogenic receptor tyrosine kinase. In contrast, ectopically expressed P-cadherin by generating P-cadherin stable cell line enhances Tie-2 expression and cell mobility. We also demonstrated that inhibition of P-cadherin by PF-03732010, a fully humanized anti-P-cadherin IgG1 monoclonal antibody, suppressed cell migration in vitro and tumor growth in BALB/c nude mice bearing SNU620 gastric cancer xenograft. The data reported here are the first to reveal that the inhibition of P-cadherin decreases tumor cell migration and blocks a tumorigenesis by down-regulation of Tie-2 in gastric cancer. This demonstrates the potential for P-cadherin to be used as a target for treatment of gastric cancer.

摘要

P-钙黏蛋白在胃癌、结肠癌、肺癌、胰腺癌和乳腺癌等实体瘤中常被上调。尽管 P-钙黏蛋白促进钙黏蛋白介导的细胞黏附,但与胃癌相关的 P-钙黏蛋白调节尚未得到广泛研究。在这项研究中,我们发现人胃癌细胞中存在 P-钙黏蛋白的表观遗传调控,这种调控是由 DNA 去甲基化药物和组蛋白去乙酰化抑制剂治疗诱导的。使用 siRNA 沉默 P-钙黏蛋白会诱导胃癌细胞凋亡,并阻断血管生成受体酪氨酸激酶 Tie-2 的表达。相比之下,通过生成 P-钙黏蛋白稳定细胞系过表达 P-钙黏蛋白会增强 Tie-2 的表达和细胞迁移能力。我们还证明,PF-03732010(一种完全人源化的抗 P-钙黏蛋白 IgG1 单克隆抗体)抑制 P-钙黏蛋白可抑制体外细胞迁移和荷瘤 BALB/c 裸鼠中 SNU620 胃癌异种移植物的肿瘤生长。这里报告的数据首次揭示了抑制 P-钙黏蛋白可通过下调胃癌中的 Tie-2 来减少肿瘤细胞迁移并阻断肿瘤发生。这表明 P-钙黏蛋白有可能成为治疗胃癌的靶点。

相似文献

1
Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer.下调 P-钙黏蛋白表达抑制胃癌细胞迁移和肿瘤生长
Invest New Drugs. 2012 Aug;30(4):1404-12. doi: 10.1007/s10637-011-9710-9. Epub 2011 Jul 1.
2
Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo.硫化砷在体外和体内均可抑制胃癌细胞的迁移和侵袭。
Drug Des Devel Ther. 2015 Oct 9;9:5579-90. doi: 10.2147/DDDT.S89805. eCollection 2015.
3
C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.C 型凝集素样受体 2 通过抑制磷酸肌醇 3-激酶亚基的表达来抑制胃癌细胞的 AKT 信号和侵袭活性。
Gastroenterology. 2016 May;150(5):1183-1195.e16. doi: 10.1053/j.gastro.2016.01.034. Epub 2016 Feb 6.
4
Downregulation of CD24 inhibits invasive growth, facilitates apoptosis and enhances chemosensitivity in gastric cancer AGS cells.下调 CD24 抑制胃癌 AGS 细胞的侵袭生长、促进细胞凋亡并增强化疗敏感性。
Eur Rev Med Pharmacol Sci. 2013 Jul;17(13):1709-15.
5
microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.微小RNA-203通过靶向细胞外信号调节激酶1/2/蜗牛蛋白/上皮钙黏蛋白信号通路抑制胃癌细胞的侵袭。
Cancer Biomark. 2017;19(1):11-20. doi: 10.3233/CBM-160167.
6
Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.启动子 CpG 岛甲基化导致胃癌中双特异性磷酸酶 5 下调及其在癌变中的潜在作用。
Am J Pathol. 2013 Apr;182(4):1275-85. doi: 10.1016/j.ajpath.2013.01.004. Epub 2013 Feb 10.
7
Tepotinib Inhibits the Epithelial-Mesenchymal Transition and Tumor Growth of Gastric Cancers by Increasing GSK3β, E-Cadherin, and Mucin 5AC and 6 Levels.特泊替尼通过增加 GSK3β、E-钙黏蛋白和黏蛋白 5AC 和 6 的水平来抑制胃癌的上皮-间质转化和肿瘤生长。
Int J Mol Sci. 2020 Aug 21;21(17):6027. doi: 10.3390/ijms21176027.
8
Epigenetic modulation by methionine deficiency attenuates the potential for gastric cancer cell dissemination.蛋氨酸缺乏的表观遗传调控可减弱胃癌细胞扩散的潜力。
J Gastrointest Surg. 2013 Jan;17(1):39-49; discussion p. 49. doi: 10.1007/s11605-012-1996-1. Epub 2012 Sep 5.
9
Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling.靶向 CDH17 抑制 Wnt/β-catenin 信号通路下调抑制胃癌肿瘤进展。
PLoS One. 2013;8(3):e56959. doi: 10.1371/journal.pone.0056959. Epub 2013 Mar 15.
10
ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.ING5抑制胃癌细胞的增殖、凋亡、迁移和侵袭,并诱导自噬和分化:是癌变及后续进展的良好标志物。
Oncotarget. 2015 Aug 14;6(23):19552-79. doi: 10.18632/oncotarget.3735.

引用本文的文献

1
Modulation of a conformational ensemble by a small molecule that inhibits key protein-protein interactions involved in cell adhesion.小分子通过调节构象平衡来抑制参与细胞黏附的关键蛋白-蛋白相互作用。
Protein Sci. 2023 Sep;32(9):e4744. doi: 10.1002/pro.4744.
2
3D Chromatin Architecture Re-Wiring at the Loci Contributes to E-Cadherin to P-Cadherin Expression Switch in Gastric Cancer.3D染色质结构在基因座处的重新布线促进了胃癌中E-钙黏蛋白向P-钙黏蛋白表达的转换。
Biology (Basel). 2023 May 31;12(6):803. doi: 10.3390/biology12060803.
3
A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.

本文引用的文献

1
PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity.PF-03732010:一种针对 P 型钙黏蛋白的全人源单克隆抗体,具有抗肿瘤和抗转移活性。
Clin Cancer Res. 2010 Nov 1;16(21):5177-88. doi: 10.1158/1078-0432.CCR-10-1343. Epub 2010 Sep 9.
2
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.曲妥珠单抗联合化疗与单纯化疗治疗 HER2 阳性晚期胃或胃食管交界腺癌(ToGA):一项开放标签、随机对照的 3 期临床试验。
Lancet. 2010 Aug 28;376(9742):687-97. doi: 10.1016/S0140-6736(10)61121-X. Epub 2010 Aug 19.
3
PF-06671008(一种针对 P-钙黏蛋白的双特异性 T 细胞衔接疗法)治疗晚期实体瘤的 1 期剂量递增研究。
Front Immunol. 2022 Apr 14;13:845417. doi: 10.3389/fimmu.2022.845417. eCollection 2022.
4
Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.钙黏蛋白 3 是胶质母细胞瘤中具有预后价值的新型致癌生物标志物。
Mol Oncol. 2022 Jul;16(14):2611-2631. doi: 10.1002/1878-0261.13162. Epub 2022 Jun 10.
5
Structure-Based Virtual Screening Allows the Identification of Efficient Modulators of E-Cadherin-Mediated Cell-Cell Adhesion.基于结构的虚拟筛选可鉴定出有效调节 E-钙黏蛋白介导的细胞间黏附的调节剂。
Int J Mol Sci. 2019 Jul 11;20(14):3404. doi: 10.3390/ijms20143404.
6
The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanoma.表皮极性蛋白Par3是恶性黑色素瘤的一种非细胞自主性抑制因子。
J Exp Med. 2017 Feb;214(2):339-358. doi: 10.1084/jem.20160596. Epub 2017 Jan 17.
7
Disruption of cell adhesion by an antibody targeting the cell-adhesive intermediate (X-dimer) of human P-cadherin.抗体靶向人 P 钙黏蛋白细胞黏附中间物(X-二聚体)导致细胞黏附破坏。
Sci Rep. 2017 Jan 3;7:39518. doi: 10.1038/srep39518.
8
P-cadherin and the journey to cancer metastasis.P-钙黏蛋白与癌症转移之旅
Mol Cancer. 2015 Oct 6;14:178. doi: 10.1186/s12943-015-0448-4.
9
The X-ray structure of human P-cadherin EC1-EC2 in a closed conformation provides insight into the type I cadherin dimerization pathway.处于闭合构象的人P-钙黏蛋白EC1-EC2的X射线结构为了解I型钙黏蛋白的二聚化途径提供了线索。
Acta Crystallogr F Struct Biol Commun. 2015 Apr;71(Pt 4):371-80. doi: 10.1107/S2053230X15003878. Epub 2015 Mar 20.
10
The influence of the CHIEF pathway on colorectal cancer-specific mortality.CHIEF通路对结直肠癌特异性死亡率的影响。
PLoS One. 2014 Dec 26;9(12):e116169. doi: 10.1371/journal.pone.0116169. eCollection 2014.
Targeting the ANGPT-TIE2 pathway in malignancy.
针对恶性肿瘤中的 ANGPT-TIE2 通路。
Nat Rev Cancer. 2010 Aug;10(8):575-85. doi: 10.1038/nrc2894.
4
Modulation of E-cadherin expression by K-Ras; involvement of DNA methyltransferase-3b.E-钙黏蛋白表达的 K-Ras 调控;DNA 甲基转移酶-3b 的参与。
Carcinogenesis. 2010 Jul;31(7):1194-201. doi: 10.1093/carcin/bgq071. Epub 2010 Apr 7.
5
Targeting metabolic transformation for cancer therapy.针对癌症治疗的代谢重编程。
Nat Rev Cancer. 2010 Apr;10(4):267-77. doi: 10.1038/nrc2817. Epub 2010 Mar 19.
6
P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance.胃腺癌中 P-钙黏蛋白的表达:调控机制及其预后意义。
Hum Pathol. 2010 Jun;41(6):877-85. doi: 10.1016/j.humpath.2009.04.031. Epub 2010 Mar 16.
7
Frequent CDH3 demethylation in advanced gastric carcinoma.晚期胃癌中CDH3频繁去甲基化。
Anticancer Res. 2009 Oct;29(10):3945-7.
8
A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival.一种与“K-Ras 成瘾”相关的基因表达特征揭示了上皮-间质转化(EMT)和肿瘤细胞存活的调节因子。
Cancer Cell. 2009 Jun 2;15(6):489-500. doi: 10.1016/j.ccr.2009.03.022.
9
Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters.Tie2介导的恶性胶质瘤多药耐药与ABC转运蛋白的上调有关。
Oncogene. 2009 Jun 18;28(24):2358-63. doi: 10.1038/onc.2009.103. Epub 2009 May 4.
10
Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.鉴定一种新型肿瘤相关抗原,钙黏蛋白3/ P-钙黏蛋白,作为胰腺癌、胃癌和结直肠癌免疫治疗的潜在靶点。
Clin Cancer Res. 2008 Oct 15;14(20):6487-95. doi: 10.1158/1078-0432.CCR-08-1086.